Comparison of three PET dopamine D2-like receptor ligands, [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone, in rats

Annals of Nuclear Medicine

Volumn 13, Issue 3, 1999, Pages 161-167

  Ishiwata, Kiichi ^a   Hayakawa, Nobutaka ^b   Ogi, Nobuo ^b   Oda, Keiichi ^b   Toyama, Hinako ^b   Endo, Kazutoyo ^b   Tanaka, Akira ^b   Senda, Michio ^b  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b NONE

Author keywords

Dopamine D2 like receptor; N methylspiperone; Nemonapride; PET; Raclopride; Rat

Indexed keywords

CARBON 11; DOPAMINE 2 RECEPTOR; EMONAPRIDE; RACLOPRIDE; SPIPERONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DIAGNOSTIC IMAGING; IN VIVO STUDY; LIGAND BINDING; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

EID: 0032791833     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164856     Document Type: Article

References (39)

1. 11C-raclopride in living human brain - a search for extrastriatal central D2-dopamine receptors by PET. Psychopharmacology 94: 471-478, 1988.
2. 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem Pharmacol 34: 2251-2259, 1985.
3. Wagner HN, Burns HD, Dannals RF, Wong DF, Langstrom B, Duelfer T, et al. Imaging dopamine receptors in the human brain by positron emission tomography. Science 221: 1264-1266, 1993.
4. 2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2 J. Nucl Med 30: 515-522, 1989.
5. Hatazawa J, Hatano K, Ishiwata K, Itoh M, Ido T, Kawashima K, et al. Measurement of D2 dopamine receptor-specific carbon-11-YM-01951-2 binding in the canine brain by PET: Importance of partial volume correction. J Nucl Med 32:713-718, 1991.
6. Itoh M, Yamaguchi S, Meguro K, Fujiwara T, Iwata R, Ido T, et al. Neuroreceptor PET; Assessment of dopamine neurotransmission in dementia. In Brain, Heart and Tumor Imaging. Updated PET and MRI, Ochi H, et al. (ed.), Amsterdam , Elsevier Science, pp. 101-105, 1995.
7. 11C]YM-09151-2 and positron emission tomography. Eur J Neurol 4: 221-226, 1997.
8. 11C]nemonapride in the mouse and rat brain. Ann Nucl Med 11: 21-26, 1997.
9. 3H]raclopride to rat and human brain membranes. J Neurochem 55: 2048-2057, 1990.
10. 3H]raclopride in reserpine-treated mouse brain. J Neural Transm 85: 1-10, 1991.
11. 3H]raclopride binding in the rat brain. Synapse 9: 188-194, 1991.
12. 3H]raclopride for dopamine D-2 receptor binding to rat striatum. Eur J Pharmacol 173: 177-182, 1989.
13. 3H-N-methylspiperone to dopamine and serotonin receptors. Life Sci 40: 987-995, 1987.
14. 2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychia 152: 1444-1449, 1995.
15. Goyer PF, Berridge MS, Morris ED, Semple WE, Compton-Toth BA, Schulz SC, et al. PET measurements of neuroreceptor occupancy by typical and atypical neuroleptics. J Nucl Med 37: 1122-1127, 1996.
16. 2 dopamine receptor occupancy induced by olanzapine in healthy subjects. Neuropsychopharmacology 16: 1-7, 1997.
17. Seeman P, Guan HC, Van Tol HHM. Dopamine D4 receptors elevated in schizophrenia. Nature 365: 441-445, 1993.
18. 3H]nemonapride. J Neurochem 64: 1413-1415, 1995.
19. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610-614, 1991.
20. 125I]epidepride. Eur J Pharmacol 286: R3-R5, 1995.
21. 4 receptors in drug-treated schizophrenia. Eur J Pharmacol 281: R5-R6, 1995.
22. Reynolds GP. Dopamine D4 receptors schizophrenia? J Neurochem 66: 881-882, 1996.
23. 3H]nemonapride. Eur J Pharmacol 301: R1-R3, 1996.
24. 3H]raclopride in postmortem human brains. Brain Res 765: 7-12, 1997.
25. 2 receptor subtypes. Neuroreport 7: 1057-1061, 1996.
26. 11C]nemonapride. Nucl Med Biol 26: 291-296, 1999.
27. Cutler PD, Cherry SR, Hoffman EJ, Digby WM, Phelps ME. Design features and performance of a PET system for animal research. J Nucl Med 33: 595-604, 1992.
28. Watanabe M, Uchida H, Okada H, Shimizu K, Satoh N, Yoshikawa E, et al. A high resolution PET for animal studies. IEEE Trans Med Imag 11: 577-580, 1992.
29. Marriott CJ, Cadorette JE, Lecomte R, Scasnar V, Rousseau J, van Lier JE. High-resolution PET imaging and quantitation of pharmaceutical biodistributions in a small animal using avalanche photodiode detectors. J Nucl Med 35: 1390-1397, 1994.
30. Bloomfield PM, Myers R, Hume SP, Spinks TJ, Lammertsma AA, Jones T. Three-dimensional performance of a small-diameter positron emission tomograph. Phys Med Biol 42: 389-400, 1997.
31. Hume SP, Lammertsma AA, Myers R, Rajeswaran S, Bloomfield PM, Ashworth S, et al. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease. J Neurosci Methods 67: 103-122, 1996.
32. Fricker RA, Torres EM, Hume SP, Myers R, Opacka-Juffrey J, Ashworth S, et al. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour. Neuroscience 79: 711-721, 1997.
33. 2 receptors in the rat brain: an in vivo study using positron emission tomography. J Neurosci 16: 7670-7677, 1996.
34. 2 receptor binding after chronic binge cocaine: a positron emission tomography study in rats. Neuropsychopharmacology 19: 145-153, 1998.
35. 11C]methylspiperone with high specific activity and high radiochemical purity for PET studies: suppression of its radiolysis. Appl Radiat Isot 41: 593-599, 1990.
36. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed., San Diego, Academic Press, Inc., 1986.
37. Kuge Y, Minematsu K, Hasegawa Y, Yamaguchi T, Mori H, Matsuura H, et al. Positron emission tomography for quantitative determination of glucose metabolism in normal and ischemic brains in rats: an insoluble problem by the Harderian glands. J Cereb Blood Flow Metab 17: 116-120, 1997.
38. Ouchi Y, Tsukada H, Kakiuchi T, Nishiyama S, Futatsubashi M. Changes in cerebral blood flow and postsynaptic muscarinic cholinergic activity in rats with bilateral carotid artery ligation. J Nucl Med 39: 198-202, 1998.
39. 11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey. Brain Res 663: 191-198, 1994.